Navigation Links
Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
Date:1/13/2009

MEXICO CITY, Jan. 13 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces that based on the main preliminary indicators obtained at the close of the fourth quarter of 2008, the Company expects to report slightly lower results than the original growth expectations. However, product sales at the point of sale continue to be in line with original projections.

Despite favorable acceptance at the point of sale, some of Genomma Lab's clients chose to marginally reduce inventory levels during the last two weeks of December, in light of the current economic situation.

During the fourth quarter, the Company maintained a strict focus on working capital, placing the Company in a very solid position in terms of liquidity.

Genomma Lab will report fourth quarter results on February 17, 2009, followed by the quarterly conference call, which will take place on the following day.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab's shares trade on the Mexican Stock Exchange under the ticker symbol "LAB".

    Web Site: www.genommalab.com

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York:
    i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Genomma Lab, New Participant in Market-Maker Program
2. Genomma Lab Announces Initiation of Stock Repurchase Fund
3. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
4. Genomma Lab Announces 2009 Earnings Guidance
5. Genomma Lab Internacional Acquires UNIGASTROZOL
6. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
7. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
8. American Journal of Nursing announces 2008 Book of the Year Awards
9. AllMed Announces PeerScore Solutions for Hospital Peer Review
10. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
11. Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... The Aresty ... of corporate finance programs to address the increasingly complex educational needs of today's ... their knowledge of sophisticated corporate finance and will increase their ability to confidently ...
(Date:3/30/2017)... ... March 30, 2017 , ... This morning, ... President Trump expressing their support for an independent Vaccine Safety Commission. Five of ... one medical journalist, will hold a press conference at 9:00 AM Friday, ...
(Date:3/29/2017)... ... 2017 , ... Full Contact K9, an Atlanta-based dog services provider, has recently ... assists dog owners in creating legally-enforceable pet trusts for their canine companions. , ... to protect their new companion. Says Evan Dunbar, CEO of Full Contact K9, “When ...
(Date:3/29/2017)... ... ... Sports Brand EXOUS Bodygear announced today a special sale price for the ... days of March, the price will be only $19.97. The EXOUS Bodygear 65cm ... (regular retail price $19.97). , The special promotional prices are to help individuals get ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... receive FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or ... teeth efficiently, compared to traditional orthodontic treatment. Depending on each patient’s case, treatment ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... Centers & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected ... The Untapped Proton Therapy Market for South Korea ... Proton Therapy plays an important role in delivering comprehensive cancer care ...
(Date:3/29/2017)... 2017  Zynex (OTCQB: ZYXI), an innovative medical technology company ... devices for pain management, stroke rehabilitation, cardiac monitoring and ... Company,s 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 ... Company expects to file its 2016 full year financial ... ...
(Date:3/29/2017)... India , March 29, 2017 According to ... by Detection Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal ... Forecast to 2021" published by MarketsandMarkets, the market is expected to reach ... a CAGR of 6.5% from 2016 to 2021. ... ...
Breaking Medicine Technology: